Roche Holding AG

RHHVF

Drug Manufacturers - General · Healthcare

Exchange

Other OTC

Winston Score

Winston is happy

A high-quality business with solid fundamentals.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Exceptional

Growth

Mixed

Cash Flow

Exceptional

Stability

Strong

Valuation

Good

Dividends

Strong

Track this stock — start free trial

Winston Score History

The full picture

Roche is a Swiss healthcare company that makes medicines and medical tests. Its pharmaceutical division sells treatments for cancer, multiple sclerosis, and eye diseases — with well-known drugs like Herceptin, Avastin, and Ocrevus. Its diagnostics division makes lab equipment and tests used by hospitals and clinics worldwide, making Roche one of the largest diagnostics companies on the planet.

Roche earns money by selling prescription drugs directly to hospitals and healthcare systems, and by selling diagnostic instruments along with the consumable test kits they require. The company operates globally, with strong revenue from the US, Europe, and Japan, and generates over $50 billion in annual sales. Its deep pipeline of cancer drugs and its combined pharma-plus-diagnostics model give it a competitive edge, but a key risk is patent expiration on older blockbuster drugs, which opens the door to cheaper biosimilar competitors that can quickly erode sales.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

73.7%

Premium pricing power — 73.7% gross margin

Profit after running costs

Operating Margin

31.1%

Excellent — 31.1% operating margin

Return on the money invested

ROCE

27.9%

Exceptional — 27.9% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-4.3%

Shrinking sales (-4.3% YoY)

Profit growth

EPS YoY

+29.5%

Earnings growing fast (+29.5% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

149%

Turns 149% of profit into real cash

Spare cash per sale

FCF Margin

24.2%

Converts sales into free cash efficiently (24.2%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.97

Moderate — manageable debt (0.97)

Covers its interest

Interest Cover

12.97x

Comfortably covers interest (13.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

30.1x

no trend

Pricey — P/E 30.1

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

+14.7

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (30.1 → 15.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

2.72%

no trend

Moderate income — 2.72% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record

Dividend Growth

+18.6%

no trend

Dividend growing fast (18.6% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial